Analyst Consensus ?
ConsensusHold44 ratings
Bullish2352.3%
Neutral1840.9%
Bearish36.8%
Monster Beverage Corporation · MNST · FY2026 Q1 · Calendar Q2 2026
Monster Q1 2026: Record $2.35B Revenue, 27% Growth, Innovation Pipeline Accelerates
Monster Beverage delivered a record Q1 2026 with net sales of $2.35 billion, up 27% year-over-year, surpassing $2 billion for the second consecutive quarter. The beat was broad-based, with double-digit growth across every geographic region, driven by a strong innovation pipeline including FLRT (female-focused line), Storm (wellness brand), and new Ultra variants. International markets now represent approximately 45% of total revenue. EPS of $0.58 exceeded the consensus estimate of $0.527 by roughly 10%, while revenue beat by approximately 9%. The stock surged 13.6% on the session following the report, on 3.4x baseline volume, with a further 2.5% drift higher. Despite gross margin pressure from aluminum tariffs, freight-in costs, and product mix, management expressed confidence in sustained growth through pricing actions, innovation, and the Coca-Cola distribution partnership. The…
Reported After market closeNASDAQConsumer Defensive
$95.59B market cap
100quality score
Company context
Snapshot as of publicationMonster Beverage Corporation is a global entity primarily involved in the innovation, marketing, sale, and distribution of energy beverages and concentrates. Its business operations are categorized into three main divisions: Monster Energy Drinks, Strategic Brands, and a segment designated as "Other." The company boasts an extensive product portfolio, encompassing a wide array of carbonated energy drinks, alongside various non-carbonated options. These include ready-to-drink iced teas, lemonades, diverse juice cocktails, single-serving juices, and fruit beverages. Additionally, their offerings extend to ready-to-drink dairy and coffee-based concoctions, specialized sports drinks, single-serve still waters, and a selection of sodas described as natural, sparkling juices, and flavored sparkling beverages. Monster Beverage distributes its products through a comprehensive network, supplying bottlers and full-service beverage distributors.…
Earnings scorecard
Reported versus consensus
Reported EPS
$0.58
Consensus $1
EPS surprise
+10.1%
Reported versus consensus
Reported revenue
$2.35B
Consensus $2.16B
Revenue surprise
+8.9%
Reported versus consensus
Earnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$97.74Current
$23Low
$73.21Average
$105High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Deutsche Bank | Hold | Buy | Downgrade | Jul 20, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 20, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 16, 2026 |
| Stifel | Buy | Buy | Maintain | Jul 16, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 14, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 8, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jun 1, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | May 8, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | May 8, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | May 8, 2026 |
| Rothschild & Co | Buy | Neutral | Upgrade | May 6, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Feb 27, 2026 |
| TD Cowen | Hold | Hold | Maintain | Jan 8, 2026 |
| B of A Securities | Buy | Buy | Maintain | Nov 7, 2025 |
| Roth Capital | Neutral | Neutral | Maintain | Aug 13, 2025 |
| Redburn Atlantic | Neutral | Buy | Downgrade | Jul 9, 2025 |
| Roth MKM | Neutral | Neutral | Maintain | May 14, 2025 |
| CICC | Outperform | Market Perform | Upgrade | May 12, 2025 |
| Truist Securities | Sell | Sell | Maintain | Apr 24, 2025 |
| Needham | Hold | Hold | Maintain | Feb 28, 2025 |
| HSBC | Buy | Buy | Maintain | Mar 6, 2024 |
| MKM Partners | Neutral | Neutral | Maintain | Aug 10, 2023 |
| Goldman Sachs | Buy | Buy | Maintain | May 5, 2023 |
| Wedbush | Neutral | Neutral | Maintain | Mar 30, 2023 |
| Argus Research | Buy | Buy | Maintain | Mar 21, 2023 |
| Redburn Partners | Buy | Neutral | Upgrade | Mar 6, 2023 |
| Bernstein | Outperform | Market Perform | Upgrade | May 18, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 18, 2022 |
| Jefferies | Hold | Buy | Downgrade | Oct 13, 2021 |
| Guggenheim | Buy | Neutral | Upgrade | Mar 20, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Feb 28, 2020 |
| Cowen & Co. | Market Perform | Outperform | Downgrade | Oct 17, 2019 |
| Macquarie | Neutral | Outperform | Downgrade | Apr 1, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | Sep 18, 2018 |
| Susquehanna | Negative | Neutral | Downgrade | Nov 20, 2017 |
| Bank of America | Neutral | Neutral | Maintain | Mar 22, 2016 |
| CLSA | Buy | Outperform | Maintain | Feb 26, 2016 |
| ISI Group | Buy | Buy | Maintain | Sep 22, 2014 |
| Longbow Research | Neutral | Underperform | Upgrade | Aug 8, 2014 |
| BTIG Research | Buy | Buy | Maintain | Jun 19, 2014 |
| Northcoast Research | Sell | Sell | Maintain | Aug 23, 2013 |
| Gabelli & Co. | Hold | Buy | Downgrade | May 9, 2013 |
| ValuEngine | Strong Buy | Strong Buy | Maintain | Nov 27, 2012 |
| Canaccord Genuity | Hold | Hold | Maintain | May 10, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $97.74. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| BMO Capital | Andrew Strelzik | $95 | $97.5 | -2.8% | Jul 20, 2026 |
| Deutsche Bank | Steve Powers | $98 | $97.5 | +0.3% | Jul 20, 2026 |
| UBS | Analyst unavailable | $104 | $99.59 | +6.4% | Jul 16, 2026 |
| Wells Fargo | Chris Carey | $105 | $96.92 | +7.4% | Jul 8, 2026 |
| Bernstein | Analyst unavailable | $95 | $92.03 | -2.8% | Jun 11, 2026 |
| Morgan Stanley | Dara Mohsenian | $103 | $88.08 | +5.4% | Jun 1, 2026 |
| Morgan Stanley | Analyst unavailable | $100 | $86.29 | +2.3% | May 10, 2026 |
| Evercore ISI | Analyst unavailable | $95 | $85.84 | -2.8% | May 8, 2026 |
| Redburn Partners | Charlie Higgs | $90 | $75.8 | -7.9% | May 6, 2026 |
| RBC Capital | Analyst unavailable | $86 | $76.19 | -12.0% | Apr 9, 2026 |
| Jefferies | Analyst unavailable | $100 | $77.52 | +2.3% | Mar 11, 2026 |
| Seaport Global | Analyst unavailable | $88 | $85.3 | -10.0% | Feb 27, 2026 |
| RBC Capital | Analyst unavailable | $88 | $84.76 | -10.0% | Feb 24, 2026 |
| Deutsche Bank | Analyst unavailable | $88 | $83.22 | -10.0% | Feb 20, 2026 |
| Argus Research | Analyst unavailable | $95 | $81.42 | -2.8% | Jan 27, 2026 |
| Morgan Stanley | Analyst unavailable | $96 | $82 | -1.8% | Jan 26, 2026 |
| BNP Paribas | Analyst unavailable | $77 | $77.91 | -21.2% | Jan 16, 2026 |
| UBS | Peter Grom | $84 | $76.95 | -14.1% | Jan 14, 2026 |
| Wells Fargo | Chris Carey | $86 | $75.75 | -12.0% | Jan 5, 2026 |
| Morgan Stanley | Analyst unavailable | $87 | $77.66 | -11.0% | Dec 23, 2025 |
| Stifel Nicolaus | Matthew Smith | $82 | $72.49 | -16.1% | Dec 12, 2025 |
| Roth Capital | Analyst unavailable | $70 | $73.98 | -28.4% | Dec 3, 2025 |
| BMO Capital | Andrew Strelzik | $73 | $74.71 | -25.3% | Dec 3, 2025 |
| Piper Sandler | Michael Lavery | $85 | $74.71 | -13.0% | Dec 3, 2025 |
| Wells Fargo | Chris Carey | $83 | $74.71 | -15.1% | Dec 3, 2025 |
| RBC Capital | Nik Modi | $81 | $74.99 | -17.1% | Dec 1, 2025 |
| Morgan Stanley | Dara Mohsenian | $81 | $72.28 | -17.1% | Nov 7, 2025 |
| Jefferies | Kaumil Gajrawala | $79 | $66.48 | -19.2% | Nov 4, 2025 |
| Stifel Nicolaus | Matthew Smith | $78 | $69.52 | -20.2% | Oct 24, 2025 |
| RBC Capital | Nik Modi | $75 | $69.57 | -23.3% | Oct 10, 2025 |
| UBS | Analyst unavailable | $72 | $68.15 | -26.3% | Oct 8, 2025 |
| RBC Capital | Nik Modi | $68 | $65.26 | -30.4% | Aug 8, 2025 |
| Wells Fargo | Chris Carey | $73 | $60.8 | -25.3% | Aug 8, 2025 |
| Piper Sandler | Michael Lavery | $74 | $64.69 | -24.3% | Aug 8, 2025 |
| Morgan Stanley | Dara Mohsenian | $70 | $63.69 | -28.4% | Jun 12, 2025 |
| Goldman Sachs | Bonnie Herzog | $67 | $62.87 | -31.5% | May 23, 2025 |
| UBS | Analyst unavailable | $57 | $54.65 | -41.7% | Mar 2, 2025 |
| Morgan Stanley | Analyst unavailable | $60 | $54.65 | -38.6% | Feb 28, 2025 |
| Deutsche Bank | Steve Powers | $61 | $52.3 | -37.6% | Nov 1, 2024 |
| Goldman Sachs | Bonnie Herzog | $63 | $45.26 | -35.5% | Aug 8, 2024 |
| BMO Capital | Andrew Strelzik | $54 | $45.32 | -44.8% | Aug 8, 2024 |
| Piper Sandler | Michael Lavery | $46 | $44.2 | -52.9% | Aug 8, 2024 |
| Jefferies | Kaumil Gajrawala | $60 | $50.53 | -38.6% | Aug 8, 2024 |
| RBC Capital | Nik Modi | $64 | $49.95 | -34.5% | Jul 1, 2024 |
| BNP Paribas | Kevin Grundy | $48 | $49.09 | -50.9% | Jun 24, 2024 |
| RBC Capital | Nik Modi | $65 | $48.52 | -33.5% | Jun 14, 2024 |
| Goldman Sachs | Bonnie Herzog | $66 | $48.72 | -32.5% | Jun 14, 2024 |
| Deutsche Bank | Steve Powers | $63 | $48.72 | -35.5% | Jun 14, 2024 |
| Jefferies | Kaumil Gajrawala | $61 | $49.77 | -37.6% | Jun 13, 2024 |
| Roth Capital | Sean McGowan | $56 | $51.16 | -42.7% | Jun 12, 2024 |
| BMO Capital | Andrew Strelzik | $56 | $54.86 | -42.7% | May 3, 2024 |
| Piper Sandler | Michael Lavery | $59 | $54.52 | -39.6% | May 3, 2024 |
| Truist Financial | Bill Chappell | $46 | $54.33 | -52.9% | Apr 25, 2024 |
| Piper Sandler | Michael Lavery | $50 | $50.3 | -48.8% | Oct 24, 2023 |
| Wedbush | Gerald Pascarelli | $23.75 | $22.76 | -75.7% | Oct 10, 2022 |
| UBS | Peter Grom | $24.75 | $22.54 | -74.7% | Aug 24, 2022 |
| Roth Capital | Sean McGowan | $25 | $24.35 | -74.4% | Jul 13, 2022 |
| Stifel Nicolaus | Mark Astrachan | $26.25 | $22.96 | -73.1% | Jun 23, 2022 |
| Morgan Stanley | Dara Mohsenian | $29.25 | $22.03 | -70.1% | Jun 18, 2022 |
| RBC Capital | Nik Modi | $25 | $22 | -74.4% | Jun 14, 2022 |
| Bernstein | Callum Elliott | $27.5 | $22.31 | -71.9% | May 18, 2022 |
| Stifel Nicolaus | Mark Astrachan | $25.75 | $18.3 | -73.7% | Mar 13, 2022 |
| Citigroup | Wendy Nicholson | $24.5 | $21.14 | -74.9% | Feb 25, 2022 |
| Credit Suisse | Kaumil Gajrawala | $27.5 | $20.32 | -71.9% | Feb 18, 2022 |
| Wells Fargo | Chris Carey | $25 | $20.81 | -74.4% | Feb 16, 2022 |
| Goldman Sachs | Bonnie Herzog | $27.25 | $24.44 | -72.1% | Jan 4, 2022 |
| Morgan Stanley | Dara Mohsenian | $27.75 | $22.91 | -71.6% | Nov 5, 2021 |
| Jefferies | Kevin Grundy | $23 | $21.33 | -76.5% | Oct 13, 2021 |
| Truist Financial | Bill Chappell | $28.75 | $22.81 | -70.6% | May 7, 2021 |
Track every rating change on MNST the moment it posts. Free to start.
Start freeMarket reaction
event-close to next-session close
Stock move
+13.6%
Event window
SPY move
+0.8%
Same window
Abnormal move
+12.8%
Stock minus SPY
Volume
3.4×
Versus trailing sessions
Subsequent drift
+2.5%
Up to 20 sessions
MNSTSPY benchmark
Follow MNST with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Revenue growth accelerated from 17.6% in Q4 2025 to 27% in Q1 2026. Net sales first crossed $2 billion in Q4 2025 ($2.13B) and scaled to $2.35B this quarter. International sales mix rose to approximately 45% of total revenue. The innovation pipeline expanded with two new brand platforms: FLRT, a female-focused line, and Storm, a wellness brand with four SKUs. Monster also became the value-share market leader in Australia, overtaking Red Bull and V. Capital returns intensified with 1.4 million shares repurchased for $100 million versus no buyback disclosure in the prior quarter. Gross margin pressure from aluminum tariffs and freight-in costs became more pronounced, though margins remained solid overall. Capex outlook shifted to increasing from not mentioned previously.
Guidance delta
Monster Beverage does not provide formal forward guidance. Both Q4 2025 and Q1 2026 calls carried a guidance sentiment of not provided. Management highlighted forward-looking plans including staggered Storm and FLRT rollouts, America 250 Ultra limited editions, expanded multipack availability in club channels, SAP S/4HANA implementation by January 2028, and continued evaluation of domestic and international pricing actions. No specific revenue or EPS targets were issued for upcoming quarters.
Key takeaways
- Q1 2026 net sales reached $2.35 billion, a 27% increase year-over-year, with double-digit growth across all geographic regions.
- Innovation continues to drive growth, highlighted by launches of FLRT (female-focused line), Storm (wellness brand), Ultra White, and additional flavors.
- International markets now account for approximately 45% of total sales, with particularly strong performance in EMEA, APAC, and Latin America.
- Gross margin was pressured by product mix, rising aluminum can costs, and freight-in expenses but remained solid overall.
- The company repurchased 1.4 million shares for $100 million and retains $400 million in remaining buyback authorization.
- Monster became the market leader on a value basis in Australia, overtaking Red Bull and V.
Management priorities
- Roll out additional Storm SKUs and expand FLRT distribution.
- Launch America 250 Ultra limited editions and broader Ultra family offerings.
- Increase multipack availability (12-pack, 24-pack), especially in club channels.
- Complete SAP S/4HANA digital transformation by January 1, 2028.
- Continue evaluating price increases and expanding affordable brands (Bang, Predator, Fury) in emerging markets.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-29T04:31:34.427705+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-29T04:31:34.424460+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.